Status:
COMPLETED
Austrian Multivessel Taxus-Stent Registry
Lead Sponsor:
Medical University of Vienna
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The aim of AUTAX study is to investigate the frequency of MACCE in patients with multivessel disease and multiple Taxus stent implantations in the "real world" stenting at 30 days, 6 and 12 months at ...
Eligibility Criteria
Inclusion
- symptomatic coronary multivessel disease
- possible percutaneous complete coronary revascularization
- age \>18 year
- significant coronary lesion at least in 2 vessels
Exclusion
- acute myocardial infarction within 48 hours
- contraindications to clopidogrel, aspirin, heparin and taxol
- pregnancy or lack of protection against pregnancy or breast-feeding during the study
- hemorrhagic diathesis
- platelet count \<100.000/ml3
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
441 Patients enrolled
Trial Details
Trial ID
NCT00738686
Start Date
June 1 2004
End Date
May 1 2008
Last Update
August 21 2008
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Landeskrankenhaus
Bruck an der Mur, Austria
2
Department of Interventional Cardiology, Academic Hospital
Feldkirch, Austria
3
Landeskrankenhaus Graz-West
Graz, Austria
4
Allgemeines Krankenhaus der Stadt Linz
Linz, Austria